The guinea pig model of diisocyanate sensitization. II. Physiologic studies.
D000818:Animals; D001249:Asthma / Q000139:chemically induced / Q000276:immunology / Q000503:physiopathology*; D003485:Cyanates / Q000009:adverse effects / Q000276:immunology*; D004195:Disease Models, Animal; D005260:Female; D006168:Guinea Pigs; D007106:Immune Sera / Q000008:administration & dosage; D007073:Immunoglobulin E / Q000008:administration & dosage; D017953:Isocyanates; D009784:Occupational Diseases / Q000139:chemically induced / Q000276:immunology / Q000503:physiopathology*; D012129:Respiratory Function Tests; D014051:Toluene 2,4-Diisocyanate / Q000009:adverse effects / Q000276:immunology*; D014168:Transferrin / Q000276:immunology
D003485:Cyanates; D007106:Immune Sera; D017953:Isocyanates; D014168:Transferrin; C015262:1,6-hexamethylene diisocyanate; D014051:Toluene 2,4-Diisocyanate; D007073:Immunoglobulin E